Key result
Molecular autopsy clarifies cause of sudden cardiac death when conventional autopsy fails.
Why the study?
Conventional autopsy often fails to identify a definitive cause of sudden cardiac death, necessitating advanced molecular autopsy approaches.
Does molecular autopsy improve the diagnostic yield and identification of at-risk relatives in cases of sudden cardiac death with inconclusive conventional autopsy?
Does molecular autopsy improve the diagnostic yield and identification of at-risk relatives in cases of sudden cardiac death with inconclusive conventional autopsy?
Molecular autopsy significantly enhances sudden cardiac death investigations, enabling definitive postmortem diagnoses and extending to preventive cardiovascular medicine via cascade screening of relatives.
Answers are grounded in this paper and cite their sources.
May aid unexplained sudden cardiac death diagnosis; leaves open standardized cascade screening protocols pending prospective validation.
Sudden cardiac death (SCD) is a leading cause of unexpected mortality worldwide and represents a major challenge in pathology, especially when conventional autopsy fails to identify a definitive cause of death. In these cases, molecular autopsy (MA) has emerged as a valuable diagnostic approach, enabling the identification of pathogenic genetic variants associated with inherited cardiomyopathies, channelopathies, and other cardiovascular diseases. This review provides a comprehensive overview of the current role of MA in the investigation of SCD, highlighting recent advances in postmortem genetic testing and their impact on forensic practice. The evolution of sequencing technologies, from targeted gene panels to whole-exome and whole-genome sequencing, as well as new long-read sequencing approaches, is discussed. Emphasis is placed on the interpretation of genetic variants according to current international guidelines, the integration of molecular findings with autopsy, histopathological, and toxicological investigations, and the importance of multidisciplinary collaboration between forensic pathologists, molecular geneticists, cardiologists, and genetic counselors. We also examine current challenges, including variants of uncertain significance, limited genotype–phenotype correlation, ethical considerations, and the need for standardized international protocols. Finally, we explore prospects, including multi-omics technologies, artificial intelligence-assisted variant interpretation, and improved data sharing initiatives, which may improve diagnostic accuracy and facilitate clinical translation. In addition to determining cause of death, MA has become an essential tool for identifying at-risk relatives through cascade screening, thus extending the role of forensic genetics from postmortem diagnosis to preventive cardiovascular medicine.
No takes yet. Share an insight, caveat, or question.
Salzillo et al. (2026) conducted a review in Sudden cardiac death. Molecular autopsy was evaluated. Molecular autopsy has emerged as an essential diagnostic approach for identifying pathogenic genetic variants in sudden cardiac death cases when conventional autopsy fails.
Synapse has enriched 10 related papers. Consider them for comparative context: